About

SCellex is a start-up company operating in Meilahti medical campus of University of Helsinki, Finland. We develop a novel spatial transcriptomics method and chip platform to study the gene expression profiles of cells directly from tissue sections or single cells in high throughput manner.

News:

3.8.2021 OPEN POSITION(S) IN R&D!

8.6.2020 SCellex and 10 other start-ups selected to the new Health Incubator Helsinki

11.5.2020 SCellex partners with a new CancerIO consortium project on immuno-oncology

17.3.2020 Instrumentarium Science Foundation grant for SCellex

1.2.2019 Runar Bäckström Foundation grant for SCellex